glp-1 gip news The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Genetic predictors for GLP-1 weight

SFN activates the antioxidant and anti-inflammatory responses by inducing Nrf2 pathway and inhibiting NF-B

Photo by Innerbody Research Around 30-50% of American adults dont get enough sleep.1 The consequences of this insufficiency can be steep, as without a regular 7-8 hours rest per night, a person can find themselves at risk for depression, decreased cognitive function, and an increased risk of cardiovascular and endocrine dysfunction.2 For the many millions of people with sleep deficiency, a peptide called DSIP could be a solution, although some researchers might disagree

,

QR Code Verification

Persistently high homocysteine can also risk problems with the cardiovascular system and blood cell formation